Αlsavin-Αlsasyn
Advanced Joint Support
Alsanza offers advanced intra-articular solutions for the treatment of joint disorders such as osteoarthritis. With products like ALSAVIN and ALSASYN, we address both early and advanced stages of degeneration using high-purity, non-animal hyaluronic acid. From multi-injection protocols to single-dose cross-linked systems, our portfolio supports joint lubrication, shock absorption, and mechanical stability—helping reduce pain, improve mobility, and restore quality of life.
Our Orthopedic Portfolio
From early-stage discomfort to advanced degenerative joint conditions, the Alsanza orthopedic range offers flexible treatment options to meet varied clinical needs.
ALSAVIN provides high-purity, non-cross-linked sodium hyaluronate in multiple concentrations for multi-injection protocols, while ALSASYN delivers long-lasting results with a single, lightly cross-linked injection.
Together, they support joint function, reduce pain, and help restore mobility across major joints including the knee, hip, shoulder, TMJ, and wrist.
Science Behind the Formulations
Both ALSAVIN and ALSASYN are developed with pharmaceutical-grade, non-animal hyaluronic acid produced via bio-fermentation.
ALSAVIN’s linear structure ensures high viscoelasticity, reversible flow, and tissue compatibility for repeated joint lubrication.
ALSASYN features a unique Dual Operational Design, combining cross-linked and linear HA to deliver both immediate relief and sustained mechanical support.
This dual mechanism promotes shock absorption, synovial fluid stability, and prolonged joint protection from a single injection.
Products
High-Molecular Weight
NaHA for 3-5 injections
with 1 week intervals
High-Molecular Weight
NaHA for 1-3 injections
with 1 week intervals
High-Molecular Weight
NaHA for Mono Dose,
one-shot injection
Lightly Cross-Linked
NaHa with Dual Operational Design 88 mg NaHa with Mono Dose,
one-shot injection